Missionpharma Sustainability Profile
Missionpharma, officially known as Missionpharma A/S, is a leading provider of healthcare solutions headquartered in Denmark (DK). Established in 2000, the company has made significant strides in the pharmaceutical and medical supply industry, focusing on the procurement and distribution of essential medicines and medical devices across various regions, including Africa and Asia. With a commitment to improving healthcare access, Missionpharma offers a diverse range of products, including generic pharmaceuticals, surgical instruments, and diagnostic tools. Their unique approach combines quality assurance with competitive pricing, ensuring that healthcare providers receive reliable products tailored to their needs. Recognised for their dedication to social responsibility, Missionpharma has positioned itself as a trusted partner in global health initiatives, contributing to improved health outcomes in underserved communities.
DitchCarbon Score
How does Missionpharma's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Missionpharma's score of 20 is lower than 85% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Missionpharma's reported carbon emissions
As of 2024, Missionpharma, headquartered in Denmark (DK), has not disclosed specific carbon emissions data, including Scope 1, 2, or 3 emissions. The company has not set any reduction targets or initiatives, nor does it appear to have cascaded data from a parent organisation. In previous years, such as 2023, 2022, and 2021, Missionpharma also did not report any emissions figures. The absence of disclosed emissions data suggests that the company may be in the early stages of developing its climate strategy or reporting framework. Missionpharma's commitment to sustainability is evident through its ongoing efforts to enhance transparency and accountability in its environmental impact, although specific targets or achievements have not been established. The company is encouraged to adopt industry-standard climate terminology and frameworks, such as the Science Based Targets initiative (SBTi), to align with global climate goals. Overall, while Missionpharma has not yet provided quantifiable emissions data or reduction commitments, its focus on sustainability indicates a potential pathway towards future climate action.
How Carbon Intensive is Missionpharma's Industry?
How Carbon Intensive is Missionpharma's Location?
Missionpharma's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Missionpharma has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
